These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32892743)

  • 1. How to design a pre-specified statistical analysis approach to limit p-hacking in clinical trials: the Pre-SPEC framework.
    Kahan BC; Forbes G; Cro S
    BMC Med; 2020 Sep; 18(1):253. PubMed ID: 32892743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public availability and adherence to prespecified statistical analysis approaches was low in published randomized trials.
    Kahan BC; Ahmad T; Forbes G; Cro S
    J Clin Epidemiol; 2020 Dec; 128():29-34. PubMed ID: 32730852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of unexplained discrepancies between planned and conducted statistical analyses: a review of randomised trials.
    Cro S; Forbes G; Johnson NA; Kahan BC
    BMC Med; 2020 May; 18(1):137. PubMed ID: 32466758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that nonsignificant results are sometimes preferred: Reverse P-hacking or selective reporting?
    Chuard PJC; Vrtílek M; Head ML; Jennions MD
    PLoS Biol; 2019 Jan; 17(1):e3000127. PubMed ID: 30682013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-Hacking and publication bias interact to distort meta-analytic effect size estimates.
    Friese M; Frankenbach J
    Psychol Methods; 2020 Aug; 25(4):456-471. PubMed ID: 31789538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimands and Complex Innovative Designs.
    Collignon O; Schiel A; Burman CF; Rufibach K; Posch M; Bretz F
    Clin Pharmacol Ther; 2022 Dec; 112(6):1183-1190. PubMed ID: 35253205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
    Mehrotra DV
    Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group.
    Stat Med; 1999 Aug; 18(15):1905-42. PubMed ID: 10532877
    [No Abstract]   [Full Text] [Related]  

  • 14. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeking harmony: estimands and sensitivity analyses for confirmatory clinical trials.
    Mehrotra DV; Hemmings RJ; Russek-Cohen E;
    Clin Trials; 2016 Aug; 13(4):456-8. PubMed ID: 26908545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risk of Bias in Randomized Trials in General Dentistry Journals.
    Hinton S; Beyari MM; Madden K; Lamfon HA
    J Long Term Eff Med Implants; 2015; 25(4):277-88. PubMed ID: 26852636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A constructive critique of the
    Scharfstein DO
    Clin Trials; 2019 Aug; 16(4):375-380. PubMed ID: 31184495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others.
    Blümle A; Antes G; Schumacher M; Just H; von Elm E
    J Med Ethics; 2008 Sep; 34(9):e20. PubMed ID: 18757621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective outcome reporting in obesity clinical trials: a cross-sectional review.
    Rankin J; Ross A; Baker J; O'Brien M; Scheckel C; Vassar M
    Clin Obes; 2017 Aug; 7(4):245-254. PubMed ID: 28557240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.